Other studies report that serum levels of GGT are positively and strongly associated with the increased risk of type 2 diabetes over a period of three years [15], [16], and associated with increased risk for fatal cardiovascular disease (CVD) [17]. This evidence concerns the gene GGT1 and cardiovascular disorder.